Barringtonia racemosa
What's the taxonomical classification of Barringtonia racemosa?
Barringtonia racemosa belongs to the kingdom Plantae and is classified within the phylum Streptophyta. Moving through its hierarchical lineage, it is situated in the class Equisetopsida and the subclass Magnoliidae. The plant is further organized under the order Ericales and falls within the family Lecythidaceae. Finally, it is identified by its specific genus, Barringtonia, and its unique species designation, racemosa.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Lecythidaceae |
| Genus | Barringtonia |
| Species | racemosa |
What are the morphological characteristics of this plant?
Barringtonia racemosa has a medium to large tree habit characterized by spreading branches, elliptic to obovate leaves with entire margins, and terminal racemes of fragrant, showy white flowers. The leaves are typically arranged in a spiral pattern and possess prominent pinnate venation. Its inflorescences consist of dense, elongated spikes containing numerous small petals and numerous long, protruding stamens that create a brush-like appearance. The resulting fruit is a woody, indehiscent capsule that is often buoyant to facilitate dispersal by water. These morphological features collectively allow the species to thrive in riparian and wetland environments.
What is the geographical distribution of this plant?
This plant is native to the tropical coastal regions of South and Southeast Asia, specifically found along the shorelines of India, Sri Lanka, Myanmar, Thailand, and Indonesia. It typically thrives in saline environments such as mangrove swamps, estuaries, and sandy beaches. The species is often distributed across intertidal zones where it can tolerate periodic saltwater inundation. Its presence is most common in the Indo-West Pacific botanical province. These specific habitats allow the species to spread via waterborne seeds along coastal margins.
How is this plant cultivated?
This plant is cultivated by sowing its large, fleshy seeds directly into well-draining, sandy or loamy soil in tropical environments with high humidity.
It requires consistent moisture and thrives in coastal areas or near water bodies where the substrate remains damp. Regular watering is essential during the establishment phase to ensure the young saplings develop strong root systems. Sunlight requirements vary, as the plant prefers full sun to partial shade depending on its stage of growth.
Once mature, it can withstand moderate saline conditions common in maritime climates.
What parts of this plant are used medicinally?
This plant utilizes its fruit, leaves, roots, seeds, and stem for various medicinal applications in traditional healing practices. The bark from the stem is often processed to treat skin conditions or inflammatory issues. Extracts from the leaves are frequently applied topically or ingested to manage specific ailments. The roots are decocted to create remedies for internal discomforts. Additionally, the seeds and the fruit contain bioactive compounds that contribute to the plant's overall therapeutic profile.
According to a study published by "Journal of Asian natural products research", the fruit extract of Barringtonia racemosa contains the active component quercetin 3-O-rutinoside (QOR). This specific compound was isolated from the fruits of the plant for the first time and quantified using the HPLC method. While the seed extract of the plant has demonstrated antitumor properties in a mice model, research focused on the fruit extract to identify its active constituents. The isolated QOR showed dose- and time-dependent anti-proliferative activity in several leukemic cell lines. In the T-lineage acute lymphoblastic leukemia cell line MOULT-3, QOR induced programmed cell death through the activation of the mitochondria-dependent caspase cascade.
The parts of this plant that are ued medicinally are shown in the list below.
- fruit
- leaf
- roots
- seed
- stem
What traditional systems uses this plant?
This plant Barringtonia racemosa has been utilized for centuries in traditional Ayurvedic medicine and various indigenous practices to treat skin ailments, digestive issues, and inflammatory conditions. In the Ayurvedic system, different parts of the tree are prepared to address specific bodily imbalances and promote healing. Historically, local communities have used decoctions from the bark and extracts from the fruit to manage wounds and topical infections. The seeds and flowers have also played roles in ritualistic uses and folk remedies across tropical regions. These long-standing medicinal applications highlight the plant's historical significance in managing diverse health concerns.
According to a study published by "Phytotherapy research : PTR", Barringtonia racemosa presents a wide range of therapeutic applications. In the course of identifying bioactives from Indian medicinal plants, the hexane, ethanol and methanol extracts of B. racemosa seeds displayed potent yeast and intestinal alpha-glucosidase inhibitory activities. The methanol extract was found to be superior among the extracts tested. While none of the extracts exhibited pancreatic alpha-amylase inhibitory activity, the ethanol and methanol extracts accelerated the alpha-amylase enzyme activity. Interestingly, bartogenic acid isolated from the methanol extract inhibited alpha-amylase. This study provides the first report identifying alpha-glucosidase inhibitory activity in B. racemosa seed extracts and identifies bartogenic acid as a major compound in the seeds.
The hystorical systems that uses this plant are shown in the list below.
- Ayurveda
What are the pharmacological activities of Barringtonia racemosa?
This plant has diverse pharmacological activities including alpha-glucosidase inhibitory activity, amylase inhibitory activity, anti-proliferative effects, antibacterial activity, and antioxidant properties. Its ability to inhibit digestive enzymes like alpha-glucosidase and amylase suggests a significant potential for managing postprandial blood glucose levels in diabetic patients. The anti-proliferative characteristics indicate that certain compounds within the species may assist in inhibiting the growth of cancer cells. Additionally, the plant demonstrates antibacterial activity that can combat various pathogenic microorganisms. Finally, its strong antioxidant capacity helps neutralize free radicals and reduce oxidative stress within biological systems.
According to a study published by "Phytotherapy research : PTR", Barringtonia racemosa presents a wide range of therapeutic applications. Hexane, ethanol and methanol extracts of B. racemosa seeds displayed potent yeast and intestinal alpha-glucosidase inhibitory activities. The methanol extract was found to be superior among the extracts studied. While ethanol and methanol extracts accelerated alpha-amylase enzyme activity, bartogenic acid isolated from the methanol extract inhibited alpha-amylase. This study provides the first report identifying alpha-glucosidase inhibitory activity in B. racemosa seed extracts and identifies bartogenic acid as a major compound in the seeds.
The primary pharmacological activities of this plant are shown in the list below.
- alpha-glucosidase inhibitory activity
- amylase inhibitory activity
- anti-proliferative
- antibacterial activity
- antioxidant
What medicinal compounds this plant contains?
This plant contains the medicinal compounds bartogenic acid, clerodane diterpenoid, dihydromyticecin, gallic acid, and kaempferol. These bioactive constituents contribute to the diverse pharmacological profile of Barringtonia racemosa. Specifically, the presence of clerodane diterpenoids and bartogenic acid is often linked to significant biological activities. Furthermore, the polyphenolic components like gallic acid, kaempferol, and dihydromyticecin provide antioxidant and anti-inflammatory properties. These chemical elements work together to support the traditional medicinal uses of the species.
According to a study published by "Phytotherapy research : PTR", the hexane, ethanol and methanol extracts of Barringtonia racemosa seeds displayed potent yeast and intestinal alpha-glucosidase inhibitory activities. Among these, the methanol extract was found to be superior. While the ethanol and methanol extracts accelerated alpha-amylase enzyme activity, bartogenic acid isolated from the methanol extract inhibited alpha-amylase. This study represents the first report identifying alpha-glucosidase inhibitory activity in B. racemosa seed extracts. Additionally, it is the first communication to report the presence of bartogenic acid as a major compound in B. racemosa seeds.
The primary medicinal compounds of this plant are shown in the list below.
- bartogenic acid
- clerodane diterpenoid
- dihydromyticetin
- gallic acid
- kaempferol
What health conditions is this plant used for?
This plant is used for treating cancer and acute lymphoblastic leukemia, reducing oxidative damage, and managing blood sugar levels by inhibiting alpha-glucosidase activity and amylase activity. Its bioactive compounds possess significant antioxidant properties that help neutralize harmful free radicals in the body. Researchers have specifically investigated its potential to combat various malignant cell lines, including those found in leukemia. Furthermore, the plant helps regulate glucose metabolism by slowing down the enzymatic breakdown of carbohydrates. These diverse pharmacological activities highlight its importance in traditional and modern medicinal studies.
According to a study published by "PeerJ", the antioxidant-rich leaf extract of Barringtonia racemosa significantly alters the expression of genes involved in methylglyoxal degradation III. Microarray analysis showed that a total of 138 genes were significantly altered in response to the extract treatment with a p < 0.05 and a fold change difference of at least 1.5. The most significantly up-regulated gene was SERPINE1 at 2.8-fold, while HAMP was the most significantly down-regulated gene at 6.5-fold. An analysis revealed the top network affected by the extract had a score of 44 related to cancer, cell death and survival, and cellular movement. Because the extract can regulate genes involved in the glycolytic process and methylglyoxal degradation, it has the potential to be developed into a novel chemopreventive agent.
The main health conditions this plant is used for are shown in the list below.
- cancer
- oxidative damage
- alpha-glucosidase activity
- amylase activity
- acute lymphoblastic leukemia
What are the herbal preparations of this plant?
This plant is used to create medicinal herbal preparations such as acetone extracts and water extracts of the leaf to utilize its bioactive compounds. The acetone extract is specifically processed to isolate various phytochemicals that possess significant pharmacological properties. Additionally, water extracts of the leaf are prepared to harness the plant's natural components for traditional healing purposes. These different extraction methods allow for the targeted recovery of specific medicinal constituents. Researchers study these preparations to better understand their potential therapeutic applications in healthcare.
According to a study published by "African journal of traditional, complementary, and alternative medicines : AJTCAM", Barringtonia racemosa has shown great potential as an anti-tuberculosis agent. This plant was tested for antimycobacterial activity against Mycobacterium smegmati. The acetone extracts of the plant were found to be active against M. smegmati. The acetone extracts for the plants studied had MIC values ranging between 0.11-1.25 mg/ml. Barringtonia racemosa specifically demonstrated activity with an average MIC value of 0.13 mg/ml.
The main herbal preparations of this plant are shown in the list below.
- acetone extract
- water extracts of the leaf
What side effects this plant can have?
This plant can cause adverse health reactions such as skin irritation, gastrointestinal distress, and potential toxicity if ingested in uncontrolled amounts. Contact with the plant's sap or leaves often leads to contact dermatitis or localized allergic reactions on the skin. When consumed, certain compounds within the species may trigger nausea, vomiting, or abdominal pain. The presence of bioactive alkaloids means that improper dosage could lead to more serious systemic effects. Therefore, careful caution is necessary when handling or utilizing this species for medicinal purposes.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Barringtonia racemosa?
This plant Barringtonia racemosa is most effectively paired with herbs like ginger, turmeric, and holy basil to enhance its medicinal properties for skin and digestive ailments.
The addition of ginger helps to increase circulation and absorption of the plant's active compounds. Turmeric acts as a synergistic anti-inflammatory agent that complements the soothing nature of the bark and leaves. Holy basil provides an antioxidant boost that strengthens the overall topical or systemic application.
These combinations are frequently utilized in traditional Ayurvedic and regional herbal practices to maximize therapeutic benefits.